Nagano S - Search Results

1

An optimal promoter regulating cytokine transgene expression is crucial for safe and effective oncolytic virus immunotherapy.

Kawakami H, Ijichi N, Obama Y, Matsuda E, Mitsui K, Nishikawaji Y, Watanabe M, Nagano S, Taniguchi N, Komiya S, Kosai KI. Kawakami H, et al. Among authors: nagano s. Transl Res. 2024 Nov;273:32-45. doi: 10.1016/j.trsl.2024.07.002. Epub 2024 Jul 3. Transl Res. 2024. PMID: 38969167 Free article.

2

An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice.

Terazaki Y, Yano S, Yuge K, Nagano S, Fukunaga M, Guo ZS, Komiya S, Shirouzu K, Kosai K. Terazaki Y, et al. Among authors: nagano s. Hepatology. 2003 Jan;37(1):155-63. doi: 10.1053/jhep.2003.50018. Hepatology. 2003. PMID: 12500200

3

Matsunaga S, Nagano S, Onishi T, Morimoto N, Suzuki S, Komiya S. Matsunaga S, et al. Among authors: nagano s. J Neurosurg. 2003 Jan;98(1 Suppl):63-7. doi: 10.3171/spi.2003.98.1.0063. J Neurosurg. 2003. PMID: 12546390

4

Gene therapy eradicating distant disseminated micro-metastases by optimal cytokine expression in the primary lesion only: novel concepts for successful cytokine gene therapy.

Nagano S, Yuge K, Fukunaga M, Terazaki Y, Fujiwara H, Komiya S, Kosai K. Nagano S, et al. Int J Oncol. 2004 Mar;24(3):549-58. Int J Oncol. 2004. PMID: 14767539

5

A definitive role of RhoC in metastasis of orthotopic lung cancer in mice.

Ikoma T, Takahashi T, Nagano S, Li YM, Ohno Y, Ando K, Fujiwara T, Fujiwara H, Kosai K. Ikoma T, et al. Among authors: nagano s. Clin Cancer Res. 2004 Feb 1;10(3):1192-200. doi: 10.1158/1078-0432.ccr-03-0275. Clin Cancer Res. 2004. PMID: 14871999 Free article.

6

Local overexpression of HB-EGF exacerbates remodeling following myocardial infarction by activating noncardiomyocytes.

Ushikoshi H, Takahashi T, Chen X, Khai NC, Esaki M, Goto K, Takemura G, Maruyama R, Minatoguchi S, Fujiwara T, Nagano S, Yuge K, Kawai T, Murofushi Y, Fujiwara H, Kosai K. Ushikoshi H, et al. Among authors: nagano s. Lab Invest. 2005 Jul;85(7):862-73. doi: 10.1038/labinvest.3700282. Lab Invest. 2005. PMID: 15856048 Free article.

7

An efficient construction of conditionally replicating adenoviruses that target tumor cells with multiple factors.

Nagano S, Oshika H, Fujiwara H, Komiya S, Kosai K. Nagano S, et al. Gene Ther. 2005 Sep;12(18):1385-93. doi: 10.1038/sj.gt.3302540. Gene Ther. 2005. PMID: 15877049

8

Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatoma.

Yuge K, Takahashi T, Nagano S, Terazaki Y, Murofushi Y, Ushikoshi H, Kawai T, Khai NC, Nakamura T, Fujiwara H, Kosai K. Yuge K, et al. Among authors: nagano s. Int J Oncol. 2005 Jul;27(1):77-85. Int J Oncol. 2005. PMID: 15942646

9

Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication.

Kamizono J, Nagano S, Murofushi Y, Komiya S, Fujiwara H, Matsuishi T, Kosai K. Kamizono J, et al. Among authors: nagano s. Cancer Res. 2005 Jun 15;65(12):5284-91. doi: 10.1158/0008-5472.CAN-04-2657. Cancer Res. 2005. PMID: 15958575

10

In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF.

Khai NC, Takahashi T, Ushikoshi H, Nagano S, Yuge K, Esaki M, Kawai T, Goto K, Murofushi Y, Fujiwara T, Fujiwara H, Kosai K. Khai NC, et al. Among authors: nagano s. J Hepatol. 2006 Jun;44(6):1046-54. doi: 10.1016/j.jhep.2005.10.027. Epub 2005 Dec 7. J Hepatol. 2006. PMID: 16466829 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

656 results

Search Page

Filters